stoxline Quote Chart Rank Option Currency Glossary
  
Nu Skin Enterprises, Inc. (NUS)
7.56  1.14 (17.76%)    02-14 16:00
Open: 8.875
High: 10.04
Volume: 3,430,044
  
Pre. Close: 6.42
Low: 7.445
Market Cap: 376(M)
Technical analysis
2025-02-14 4:50:12 PM
Short term     
Mid term     
Targets 6-month :  10.01 1-year :  11.72
Resists First :  8.57 Second :  10.03
Pivot price 6.64
Supports First :  6.19 Second :  5.15
MAs MA(5) :  6.64 MA(20) :  6.75
MA(100) :  6.86 MA(250) :  9.64
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  20.6 D(3) :  17.4
RSI RSI(14): 63.9
52-week High :  14.64 Low :  5.94
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NUS ] has closed Bollinger Bands are 16.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.05 - 10.09 10.09 - 10.13
Low: 7.37 - 7.4 7.4 - 7.43
Close: 7.5 - 7.55 7.55 - 7.61
Company Description

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Headline News

Sat, 15 Feb 2025
Nu Skin Enterprises, Inc. Declares Quarterly Dividend of $0.06 (NYSE:NUS) - MarketBeat

Sat, 15 Feb 2025
Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load - Simply Wall St

Sat, 15 Feb 2025
Nu Skin Enterprises, Inc. (NYSE:NUS) Q4 2024 Earnings Call Transcript - Insider Monkey

Fri, 14 Feb 2025
Nu Skin Enterprises Inc. (NUS) reports earnings - Quartz

Fri, 14 Feb 2025
Nu Skin Enterprises Inc (NUS) Q4 2024 Earnings Call Highlights: Strong Revenue Performance ... - Yahoo Finance

Thu, 13 Feb 2025
NU SKIN ENTERPRISES Earnings Results: $NUS Reports Quarterly Earnings - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Consumer Defensive
Industry:
Household & Personal Products
Shares Out 50 (M)
Shares Float 49 (M)
Held by Insiders 2.2 (%)
Held by Institutions 79.9 (%)
Shares Short 2,340 (K)
Shares Short P.Month 1,610 (K)
Stock Financials
EPS -2.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 14.22
Profit Margin -5.9 %
Operating Margin 4.2 %
Return on Assets (ttm) 5.5 %
Return on Equity (ttm) -13.5 %
Qtrly Rev. Growth -13.9 %
Gross Profit (p.s.) 26.55
Sales Per Share 35.8
EBITDA (p.s.) 4.45
Qtrly Earnings Growth 0 %
Operating Cash Flow 140 (M)
Levered Free Cash Flow 131 (M)
Stock Valuations
PE Ratio -3.62
PEG Ratio 0
Price to Book value 0.53
Price to Sales 0.21
Price to Cash Flow 2.68
Stock Dividends
Dividend 0.05
Forward Dividend 0
Dividend Yield 0.7%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android